Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Procedures, Operative | 10 | 2024 | 1930 | 2.190 |
Why?
|
Quality Improvement | 16 | 2024 | 3845 | 1.680 |
Why?
|
Thyroid Neoplasms | 7 | 2024 | 2354 | 1.330 |
Why?
|
Pancreatectomy | 6 | 2022 | 821 | 1.230 |
Why?
|
Pancreaticoduodenectomy | 8 | 2024 | 514 | 1.220 |
Why?
|
Risk Adjustment | 5 | 2020 | 596 | 1.200 |
Why?
|
Hospitals | 6 | 2024 | 3887 | 1.180 |
Why?
|
Neuroendocrine Tumors | 4 | 2023 | 654 | 1.110 |
Why?
|
Postoperative Complications | 17 | 2024 | 15794 | 1.060 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2024 | 163 | 0.950 |
Why?
|
Surgical Wound Infection | 8 | 2024 | 1544 | 0.910 |
Why?
|
Thyroidectomy | 5 | 2024 | 912 | 0.860 |
Why?
|
Antibiotic Prophylaxis | 4 | 2024 | 642 | 0.820 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2022 | 43 | 0.800 |
Why?
|
Registries | 12 | 2021 | 8320 | 0.720 |
Why?
|
Hypocalcemia | 2 | 2023 | 205 | 0.710 |
Why?
|
Lymph Node Excision | 2 | 2016 | 1260 | 0.690 |
Why?
|
Pancreatic Fistula | 3 | 2023 | 149 | 0.640 |
Why?
|
Group Practice | 1 | 2020 | 149 | 0.630 |
Why?
|
Cancer Care Facilities | 2 | 2018 | 427 | 0.610 |
Why?
|
Radiation Oncology | 1 | 2024 | 569 | 0.610 |
Why?
|
Protective Devices | 1 | 2018 | 72 | 0.590 |
Why?
|
Reoperation | 6 | 2020 | 4309 | 0.580 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2169 | 0.560 |
Why?
|
Drainage | 3 | 2020 | 1179 | 0.550 |
Why?
|
Telomere | 2 | 2013 | 941 | 0.540 |
Why?
|
Liver Neoplasms | 3 | 2022 | 4351 | 0.510 |
Why?
|
Bronchitis, Chronic | 1 | 2016 | 81 | 0.490 |
Why?
|
Leukocytes | 2 | 2013 | 2027 | 0.470 |
Why?
|
Smoke | 1 | 2016 | 243 | 0.460 |
Why?
|
Cefoxitin | 3 | 2023 | 36 | 0.450 |
Why?
|
Emphysema | 1 | 2016 | 234 | 0.440 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5446 | 0.440 |
Why?
|
Hepatectomy | 1 | 2017 | 588 | 0.440 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 581 | 0.430 |
Why?
|
Patient Readmission | 6 | 2020 | 3284 | 0.420 |
Why?
|
Neoplasms | 6 | 2024 | 22349 | 0.420 |
Why?
|
Hematoma | 1 | 2018 | 766 | 0.410 |
Why?
|
Thyroid Nodule | 3 | 2024 | 765 | 0.380 |
Why?
|
United States | 20 | 2024 | 72896 | 0.370 |
Why?
|
Endosonography | 1 | 2015 | 626 | 0.360 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 961 | 0.360 |
Why?
|
Hospital Costs | 1 | 2017 | 957 | 0.350 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.350 |
Why?
|
Laparoscopy | 1 | 2022 | 2037 | 0.350 |
Why?
|
Point-of-Care Systems | 4 | 2023 | 1216 | 0.340 |
Why?
|
Catheter Ablation | 1 | 2024 | 2788 | 0.340 |
Why?
|
Aftercare | 1 | 2016 | 914 | 0.340 |
Why?
|
Intestinal Neoplasms | 2 | 2023 | 314 | 0.340 |
Why?
|
Quality of Life | 5 | 2024 | 13466 | 0.330 |
Why?
|
Postoperative Care | 1 | 2016 | 1474 | 0.330 |
Why?
|
Colectomy | 4 | 2019 | 696 | 0.330 |
Why?
|
Preoperative Care | 2 | 2019 | 2244 | 0.330 |
Why?
|
Carbon | 1 | 2013 | 676 | 0.320 |
Why?
|
Humans | 69 | 2024 | 765823 | 0.310 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 798 | 0.300 |
Why?
|
Retrospective Studies | 23 | 2024 | 81505 | 0.290 |
Why?
|
Mortality | 2 | 2018 | 2910 | 0.290 |
Why?
|
Propensity Score | 5 | 2019 | 1967 | 0.290 |
Why?
|
Heart Arrest | 1 | 2018 | 1515 | 0.290 |
Why?
|
Middle Aged | 33 | 2024 | 223016 | 0.290 |
Why?
|
Rectal Neoplasms | 1 | 2016 | 1184 | 0.290 |
Why?
|
Bariatric Surgery | 1 | 2017 | 997 | 0.280 |
Why?
|
Physician-Patient Relations | 2 | 2020 | 3272 | 0.280 |
Why?
|
Surgery, Computer-Assisted | 1 | 2015 | 994 | 0.280 |
Why?
|
General Surgery | 1 | 2018 | 1722 | 0.280 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1805 | 0.270 |
Why?
|
Liver | 2 | 2023 | 7558 | 0.260 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2331 | 0.260 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3474 | 0.260 |
Why?
|
Occupational Exposure | 1 | 2016 | 1805 | 0.250 |
Why?
|
Benchmarking | 2 | 2024 | 1054 | 0.250 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6360 | 0.250 |
Why?
|
Liver Transplantation | 1 | 2017 | 2417 | 0.240 |
Why?
|
Aged | 27 | 2024 | 171178 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2327 | 0.240 |
Why?
|
Nutritional Status | 1 | 2013 | 1620 | 0.230 |
Why?
|
Health Expenditures | 1 | 2017 | 2386 | 0.230 |
Why?
|
Biopsy, Fine-Needle | 3 | 2024 | 1130 | 0.220 |
Why?
|
Male | 32 | 2024 | 363740 | 0.210 |
Why?
|
Patient Discharge | 1 | 2016 | 3461 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10383 | 0.200 |
Why?
|
Risk Assessment | 7 | 2024 | 24278 | 0.190 |
Why?
|
Female | 31 | 2024 | 396050 | 0.190 |
Why?
|
Quality of Health Care | 1 | 2017 | 4303 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3247 | 0.190 |
Why?
|
Length of Stay | 4 | 2019 | 6485 | 0.180 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3412 | 0.180 |
Why?
|
Databases, Factual | 6 | 2019 | 8062 | 0.180 |
Why?
|
Analgesics | 2 | 2018 | 1057 | 0.170 |
Why?
|
Prognosis | 5 | 2023 | 29915 | 0.170 |
Why?
|
Watchful Waiting | 1 | 2024 | 493 | 0.170 |
Why?
|
Fees, Pharmaceutical | 1 | 2020 | 66 | 0.170 |
Why?
|
Vitamin D | 1 | 2013 | 3272 | 0.160 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2022 | 323 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9372 | 0.150 |
Why?
|
Tumor Burden | 1 | 2024 | 1890 | 0.150 |
Why?
|
Organometallic Compounds | 1 | 2022 | 644 | 0.150 |
Why?
|
Microfluidics | 1 | 2023 | 651 | 0.150 |
Why?
|
Survival Rate | 5 | 2019 | 12821 | 0.150 |
Why?
|
Melanoma | 1 | 2016 | 5696 | 0.140 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 645 | 0.140 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 186 | 0.140 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2018 | 299 | 0.140 |
Why?
|
Perioperative Period | 1 | 2018 | 251 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11506 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5837 | 0.140 |
Why?
|
Diverticulitis, Colonic | 1 | 2018 | 140 | 0.130 |
Why?
|
Risk Factors | 8 | 2024 | 74853 | 0.130 |
Why?
|
Cholestasis | 1 | 2019 | 385 | 0.130 |
Why?
|
Anastomotic Leak | 1 | 2017 | 170 | 0.130 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2021 | 424 | 0.130 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20131 | 0.130 |
Why?
|
Logistic Models | 4 | 2019 | 13266 | 0.120 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1811 | 0.120 |
Why?
|
Adult | 18 | 2024 | 223055 | 0.120 |
Why?
|
Diet | 1 | 2013 | 8085 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2024 | 65223 | 0.120 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1448 | 0.120 |
Why?
|
Immunoassay | 3 | 2023 | 742 | 0.110 |
Why?
|
Psychometrics | 1 | 2024 | 3061 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2023 | 1349 | 0.110 |
Why?
|
Perioperative Care | 2 | 2018 | 1038 | 0.110 |
Why?
|
Canada | 1 | 2018 | 2119 | 0.100 |
Why?
|
Choice Behavior | 1 | 2018 | 846 | 0.100 |
Why?
|
Anesthetics | 1 | 2018 | 524 | 0.100 |
Why?
|
Vitamin D-Binding Protein | 1 | 2013 | 129 | 0.100 |
Why?
|
Vitamin B 6 | 1 | 2013 | 237 | 0.100 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1769 | 0.090 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 563 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2018 | 2424 | 0.090 |
Why?
|
Cohort Studies | 6 | 2024 | 41643 | 0.090 |
Why?
|
Choline | 1 | 2013 | 511 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2013 | 361 | 0.090 |
Why?
|
Methionine | 1 | 2013 | 569 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7476 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15645 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1393 | 0.090 |
Why?
|
Equipment Design | 1 | 2018 | 3488 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3229 | 0.080 |
Why?
|
Vitamin B 12 | 1 | 2013 | 531 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6839 | 0.080 |
Why?
|
Mastectomy | 1 | 2018 | 1848 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2603 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6207 | 0.080 |
Why?
|
Social Identification | 1 | 2009 | 108 | 0.080 |
Why?
|
Nanotubes | 1 | 2009 | 83 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2024 | 5302 | 0.080 |
Why?
|
Genotype | 2 | 2013 | 13023 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8725 | 0.070 |
Why?
|
Cytokines | 1 | 2023 | 7425 | 0.070 |
Why?
|
Pancreatitis | 1 | 2015 | 1087 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12520 | 0.070 |
Why?
|
Body Mass Index | 2 | 2017 | 13041 | 0.070 |
Why?
|
Mammaplasty | 1 | 2018 | 1264 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2019 | 59506 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2415 | 0.070 |
Why?
|
Limbus Corneae | 1 | 2008 | 144 | 0.070 |
Why?
|
Ethanol | 1 | 2013 | 1324 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2531 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2017 | 1379 | 0.060 |
Why?
|
Folic Acid | 1 | 2013 | 1337 | 0.060 |
Why?
|
Calcium | 2 | 2023 | 5767 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2176 | 0.060 |
Why?
|
Culture | 1 | 2009 | 622 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2013 | 16040 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10087 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8529 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3950 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3834 | 0.060 |
Why?
|
Antibodies | 2 | 2023 | 2415 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12056 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 1216 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39226 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2018 | 2428 | 0.050 |
Why?
|
Piperacillin | 1 | 2023 | 37 | 0.050 |
Why?
|
Clinical Competence | 1 | 2019 | 4860 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2023 | 41 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10570 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 1776 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2019 | 1438 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7840 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2016 | 5338 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2667 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6544 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 26276 | 0.050 |
Why?
|
Parathyroidectomy | 1 | 2023 | 244 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2649 | 0.050 |
Why?
|
Mesentery | 1 | 2022 | 200 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 314 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54798 | 0.050 |
Why?
|
Somatostatin | 1 | 2023 | 459 | 0.050 |
Why?
|
Meningioma | 1 | 2009 | 1222 | 0.040 |
Why?
|
Meningeal Neoplasms | 1 | 2009 | 1253 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 40109 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 304 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12966 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15881 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7197 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11838 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1984 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4424 | 0.040 |
Why?
|
Ebolavirus | 1 | 2021 | 250 | 0.040 |
Why?
|
Recovery of Function | 2 | 2019 | 2965 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 21501 | 0.040 |
Why?
|
Ileostomy | 1 | 2018 | 122 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2021 | 674 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 878 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2023 | 1789 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 621 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2024 | 1405 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6061 | 0.030 |
Why?
|
Intestine, Small | 1 | 2022 | 1216 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3794 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2006 | 1663 | 0.030 |
Why?
|
Biopsy | 2 | 2023 | 6765 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 59849 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1623 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2195 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2643 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2053 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9520 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2023 | 1297 | 0.020 |
Why?
|
Morbidity | 1 | 2018 | 1752 | 0.020 |
Why?
|
Overweight | 1 | 2023 | 2443 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1296 | 0.020 |
Why?
|
Glioblastoma | 1 | 2006 | 3459 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1662 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8875 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 5995 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11888 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3316 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4562 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21064 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1134 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4018 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2780 | 0.020 |
Why?
|
Korea | 1 | 2009 | 97 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3210 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2501 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2023 | 3310 | 0.020 |
Why?
|
Endoscopy | 1 | 2019 | 1852 | 0.020 |
Why?
|
Puerto Rico | 1 | 2009 | 380 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2008 | 147 | 0.020 |
Why?
|
Acculturation | 1 | 2009 | 179 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36542 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2009 | 684 | 0.020 |
Why?
|
Polyesters | 1 | 2009 | 373 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3235 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2009 | 938 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4257 | 0.020 |
Why?
|
New York City | 1 | 2009 | 734 | 0.020 |
Why?
|
Gene Expression | 2 | 2009 | 7581 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6545 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5926 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14644 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1015 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2009 | 967 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22227 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 9069 | 0.010 |
Why?
|
Adenoviridae | 1 | 2009 | 1092 | 0.010 |
Why?
|
Conjunctiva | 1 | 2008 | 477 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 2009 | 752 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2008 | 11033 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10845 | 0.010 |
Why?
|
China | 1 | 2009 | 2387 | 0.010 |
Why?
|
Adolescent | 2 | 2023 | 88794 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3802 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2006 | 1617 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7416 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6272 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2446 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13078 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5786 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2006 | 1444 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4445 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5879 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5771 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168730 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12767 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 17063 | 0.010 |
Why?
|